» Articles » PMID: 23143591

Conditional Probability of Survival Nomogram for 1-, 2-, and 3-year Survivors After an R0 Resection for Gastric Cancer

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2012 Nov 13
PMID 23143591
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Survival estimates after curative surgery for gastric cancer are based on AJCC staging, or on more accurate multivariable nomograms. However, the risk of dying of gastric cancer is not constant over time, with most deaths occurring in the first 2 years after resection. Therefore, the prognosis for a patient who survives this critical period improves. This improvement over time is termed conditional probability of survival (CPS). Objectives of this study were to develop a CPS nomogram predicting 5-year disease-specific survival (DSS) from the day of surgery for patients surviving a specified period of time after a curative gastrectomy and to explore whether variables available with follow-up improve the nomogram in the follow-up setting.

Methods: A CPS nomogram was developed from a combined US-Dutch dataset, containing 1,642 patients who underwent an R0 resection with or without chemotherapy/radiotherapy for gastric cancer. Weight loss, performance status, hemoglobin, and albumin 1 year after resection were added to the baseline variables of this nomogram.

Results: The CPS nomogram was highly discriminating (concordance index: 0.772). Surviving 1, 2, or 3 years gives a median improvement of 5-year DSS from surgery of 7.2, 19.1, and 31.6 %, compared with the baseline prediction directly after surgery. Introduction of variables available at 1-year follow-up did not improve the nomogram.

Conclusions: A robust gastric cancer nomogram was developed to predict survival for patients alive at time points after surgery. Introduction of additional variables available after 1 year of follow-up did not further improve this nomogram.

Citing Articles

Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.

Liang X, Su Y, Li X, Fu Y, Ma R, Yang R Ann Surg Oncol. 2024; 32(4):2912-2922.

PMID: 39538101 DOI: 10.1245/s10434-024-16485-1.


The conditional recurrence-free survival after R0 hepatectomy for locally advanced intrahepatic cholangiocarcinoma: A competing risk analysis based on inflammation-nutritional status.

Huang G, Xi P, Yao Z, Zhao C, Li X, Lin X Heliyon. 2024; 10(13):e33931.

PMID: 39055818 PMC: 11269833. DOI: 10.1016/j.heliyon.2024.e33931.


A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic colorectal cancer.

Luo P, Li Y, Huang C, Guo J, Yao X Discov Oncol. 2024; 15(1):179.

PMID: 38772985 PMC: 11109079. DOI: 10.1007/s12672-024-01042-9.


Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis.

Zeng H, Xue X, Chen D, Zheng B, Liang B, Que Z Int J Colorectal Dis. 2024; 39(1):54.

PMID: 38639915 PMC: 11031473. DOI: 10.1007/s00384-024-04614-x.


Survival trends and conditional survival in primary non-metastatic esophageal cancer: a SEER population-based study and external validation.

Sun W, Zhang X, Qiu Z Transl Cancer Res. 2023; 12(10):2693-2705.

PMID: 37969371 PMC: 10643951. DOI: 10.21037/tcr-23-185.


References
1.
Merrill R, Henson D, Ries L . Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998; 41(9):1097-106. DOI: 10.1007/BF02239430. View

2.
Songun I, Putter H, Meershoek-Klein Kranenbarg E, Sasako M, van de Velde C . Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010; 11(5):439-49. DOI: 10.1016/S1470-2045(10)70070-X. View

3.
Harrell Jr F, Califf R, Pryor D, Lee K, Rosati R . Evaluating the yield of medical tests. JAMA. 1982; 247(18):2543-6. View

4.
Wang S, Emery R, Fuller C, Kim J, Sittig D, Thomas C . Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer. 2007; 10(3):153-8. DOI: 10.1007/s10120-007-0424-9. View

5.
Bonenkamp J, Songun I, Hermans J, van de Velde C . Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 1996; 83(5):672-4. DOI: 10.1002/bjs.1800830526. View